Concourse Financial Group Securities, Inc. Ab Cellera Biologics Inc. Transaction History

Concourse Financial Group Securities, Inc.

$0
Q2 2025

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

100.0%

Previous 100.0%

20 transactions

Quarter	Operation	Price Per share
Q2 2025 Aug 12, 2025	BUY	$1.93 - $3.8 $0 - $0
Q1 2025 May 14, 2025	BUY	$2.2 - $3.53 $0 - $0
Q4 2024 Feb 13, 2025	BUY	$2.48 - $3.15 $0 - $0
Q3 2024 Oct 10, 2024	BUY	$2.39 - $3.49 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$2.73 - $4.73 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$4.29 - $5.97 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$3.91 - $5.93 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$4.6 - $7.95 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$4.6 - $7.95 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$5.66 - $7.59 $0 - $0
Q1 2023 May 15, 2023	BUY	$7.31 - $11.18 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$9.48 - $14.52 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$9.2 - $13.68 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$5.72 - $10.65 $0 - $0
Q1 2022 May 09, 2022	BUY	$7.46 - $14.14 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$12.99 - $17.73 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$14.85 - $21.34 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$20.19 - $34.17 $0 - $0
Q1 2021 May 13, 2021	BUY	$23.29 - $53.2 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$39.0 - $58.9 $0 - $0

Others Institutions Holding ABCL

# of Institutions

157

Shares Held

115M

Call Options Held

538K

Put Options Held

476K

Baker Bros. Advisors LP New York, NY

27.5M
Shares

$108 Million
0.96% of portfolio
Capital World Investors Los Angeles, CA

13.4M
Shares

$52.2 Million
0.01% of portfolio
Baillie Gifford & CO

10.4M
Shares

$40.8 Million
0.04% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

8.47M
Shares

$33.1 Million
0.01% of portfolio
Credit Suisse Ag Zurich, V8

4.55M
Shares

$17.8 Million
0.02% of portfolio

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $1.11B
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account